- Decrease font
- Increase font
- Send to a friend
Click here to bookmark this page
Customize your Bookmarks:
- Type the name of the page the way you would like it to appear in "My Bookmarks";
- Click in the "Add as My Bookmarks" button.
To choose your favorite sessions, please click here.
CENTRO DE IMAGEM DIAGNÓSTICOS S.A. ("Company") (B3: AALR3), pursuant to Article 157, paragraph 4, of Law 6,404 of December 15, 1976 ("Corporation Law"), as amended, and the provisions of Securities and Exchange Commission Resolution 44, of August 23, 2021, hereby informs its shareholders and the market in general that the Company received, on October 19th, notifications sent by (i) Pátria - Brazilian Private Equity Fund III - FIP, Diagnostic Fund for Brazil - FIP, Pátria Economia Real - FIP and Brasil Private Equity III - FIP ("Sellers"), and (ii) Fonte de Saúde Fundo de Investimento em Participações Multiestratégia ("Buyer"), informing that, further to the notifications disclosed by means of the Material Fact dated August 19, 2021, it was concluded the sale of all 25,012,323 (twenty-five million, twelve thousand, three hundred and twenty-three) shares issued by the Company held by the Sellers to the Buyer.
Additionally, in compliance with art. 12 of Securities and Exchange Commission Resolution 44, of August 23, 2021, the Company also informs its shareholders and the market in general that it received, on October 19th 2021, from MAM ASSET MANAGEMENT GESTORA DE RECURSOS LTDA., manager of the Buyer, a notification informing that, after the closing mentioned above, it now holds a total of 32,302,023 (thirty-two million, three hundred and two thousand, twenty-three) shares issued by the Company, which represents an interest of 27.31% (twenty-seven wholes and thirty-one hundredths percent) of the total common shares issued.
The entire content of these notifications is attached.
São Paulo, October 20th, 2021.
To access the full document, click here.